MedTrace Logo

Descriptive Epidemiology on Management of Mucormycosis

NCT03429023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-02-12

No results posted yet for this study

Summary

This is an observational chart review of all patients with confirmed and probable diagnosis of mucormycosis at 19 centers across Indian hospital. Data will collect using a standardized CRF. All collected data will be entered into a database prior to analysis. Broadly data will be collected on demography, clinical characteristics, diagnosis, treatment and outcome for each patient. Patient will continue to receive treatment as per treating physicians advise. Primary outcome for this study will be overall survival at 45 \& 90 days.

Conditions

  • Mycoses

Sponsors & Collaborators

  • Mylan India Limited

    collaborator UNKNOWN

  • Fungal Infection Study Forum

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429023 on ClinicalTrials.gov